Fluocinolone acetonide intravitreal implants in vogt-koyanagi-harada disease

Yousuf Khalifa, Allison Loh, Nisha R. Acharya

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: To describe the use of fluocinolone acetonide implants (Retisert) in Vogt-Koyanagi-Harada disease (VKH). Design: Interventional case series. Methods: Retrospective review of medical records. Results: Two patients with VKH requiring high-dose systemic corticosteroid therapy to control their inflammation and bilateral serous retinal detachments received bilateral fluocinolone acetonide implants. Upon tapering of systemic corticosteroids, one patient had recurrent serous retinal detachments and the other patient's anterior chamber and vitreous inflammation returned. Conclusions: The authors' experience with fluocinolone acetonide implants in VKH has been mixed with an inability to fully taper off of systemic corticosteroids.

Original languageEnglish (US)
Pages (from-to)431-433
Number of pages3
JournalOcular Immunology and Inflammation
Volume17
Issue number6
DOIs
StatePublished - Dec 2009
Externally publishedYes

Fingerprint

Fluocinolone Acetonide
Uveomeningoencephalitic Syndrome
Adrenal Cortex Hormones
Retinal Detachment
Inflammation
Anterior Chamber
Medical Records
Therapeutics

Keywords

  • Fluocinolone acetonide intravitreal implant
  • Uveitis
  • Vogt-Koyanagi-Harada

ASJC Scopus subject areas

  • Immunology and Allergy
  • Ophthalmology

Cite this

Fluocinolone acetonide intravitreal implants in vogt-koyanagi-harada disease. / Khalifa, Yousuf; Loh, Allison; Acharya, Nisha R.

In: Ocular Immunology and Inflammation, Vol. 17, No. 6, 12.2009, p. 431-433.

Research output: Contribution to journalArticle

@article{d5216b703e714b2f8996717134951b08,
title = "Fluocinolone acetonide intravitreal implants in vogt-koyanagi-harada disease",
abstract = "Purpose: To describe the use of fluocinolone acetonide implants (Retisert) in Vogt-Koyanagi-Harada disease (VKH). Design: Interventional case series. Methods: Retrospective review of medical records. Results: Two patients with VKH requiring high-dose systemic corticosteroid therapy to control their inflammation and bilateral serous retinal detachments received bilateral fluocinolone acetonide implants. Upon tapering of systemic corticosteroids, one patient had recurrent serous retinal detachments and the other patient's anterior chamber and vitreous inflammation returned. Conclusions: The authors' experience with fluocinolone acetonide implants in VKH has been mixed with an inability to fully taper off of systemic corticosteroids.",
keywords = "Fluocinolone acetonide intravitreal implant, Uveitis, Vogt-Koyanagi-Harada",
author = "Yousuf Khalifa and Allison Loh and Acharya, {Nisha R.}",
year = "2009",
month = "12",
doi = "10.3109/09273940903267936",
language = "English (US)",
volume = "17",
pages = "431--433",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Fluocinolone acetonide intravitreal implants in vogt-koyanagi-harada disease

AU - Khalifa, Yousuf

AU - Loh, Allison

AU - Acharya, Nisha R.

PY - 2009/12

Y1 - 2009/12

N2 - Purpose: To describe the use of fluocinolone acetonide implants (Retisert) in Vogt-Koyanagi-Harada disease (VKH). Design: Interventional case series. Methods: Retrospective review of medical records. Results: Two patients with VKH requiring high-dose systemic corticosteroid therapy to control their inflammation and bilateral serous retinal detachments received bilateral fluocinolone acetonide implants. Upon tapering of systemic corticosteroids, one patient had recurrent serous retinal detachments and the other patient's anterior chamber and vitreous inflammation returned. Conclusions: The authors' experience with fluocinolone acetonide implants in VKH has been mixed with an inability to fully taper off of systemic corticosteroids.

AB - Purpose: To describe the use of fluocinolone acetonide implants (Retisert) in Vogt-Koyanagi-Harada disease (VKH). Design: Interventional case series. Methods: Retrospective review of medical records. Results: Two patients with VKH requiring high-dose systemic corticosteroid therapy to control their inflammation and bilateral serous retinal detachments received bilateral fluocinolone acetonide implants. Upon tapering of systemic corticosteroids, one patient had recurrent serous retinal detachments and the other patient's anterior chamber and vitreous inflammation returned. Conclusions: The authors' experience with fluocinolone acetonide implants in VKH has been mixed with an inability to fully taper off of systemic corticosteroids.

KW - Fluocinolone acetonide intravitreal implant

KW - Uveitis

KW - Vogt-Koyanagi-Harada

UR - http://www.scopus.com/inward/record.url?scp=72449152649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72449152649&partnerID=8YFLogxK

U2 - 10.3109/09273940903267936

DO - 10.3109/09273940903267936

M3 - Article

VL - 17

SP - 431

EP - 433

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 6

ER -